MedTrace Logo

Ultrasound to Predict Steal-Syndrome After Arteriovenous-Fistula Creation (UPSAC - Trial)

NCT01468506 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2014-09-25

No results posted yet for this study

Summary

The purpose of this study is to analyze and identify pre-, intra-, and post- operative parameters that predict Steal-Syndrome with distal malperfusion after Arterio-Venous Fistulas (AVF) as primary endpoint. Secondary endpoints are pre-, intra-, and post- operative parameters that predict patency and fistula maturation.

Conditions

Sponsors & Collaborators

  • Baptist Health South Florida

    lead OTHER

Principal Investigators

  • Athanassios Tsoukas, MD · Baptist Hospital Miami, BCVI

  • Heiko Uthoff, MD · Baptist Hospital Miami, BCVI

  • Philipp Geisbuesch, MD · Baptist Hospital Miami, BCVI

  • Raul Herrera, MD · Baptist Hospital of Miami, Baptist Cardiac and Vascular Institute

  • Barry Katzen, MD · Medical Director Baptist Cardiac and Vascular Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01468506 on ClinicalTrials.gov